Stories to Prevent (StoP) HPV Cancers
Milton S. Hershey Medical Center · NCT06808776
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18+ · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 200
- US sites recruiting
- 1
- Study start
- November 18, 2025
- Record last updated
- February 24, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
This randomized controlled trial (RCT) evaluates the association of a narrative communication intervention on human papillomavirus (HPV) vaccination rates among 9- to 12-year-olds. The intervention is a brief video from local cancer survivors narrating their stories with an HPV-related cancer diagnosis and recommending the HPV vaccine for cancer prevention. RCT participants will be the parents (n=200) of children ages 9-12 who have not initiated HPV vaccination. Participants will be randomized (1:1) to our intervention or control (placebo video) one week before their child's next primary care visit. Our primary outcome is HPV vaccine initiation (first dose of the HPV vaccine series) among children ages 9-12 at the time of the wellness visit. The study also explores the effect of narratives on theory-based mediators of HPV vaccination, including parents' cognitive (e.g., risk perception) and emotional reactions (e.g., hope, anticipated regret).
Being studied: Cancer survivor narrative; Healthy eating tips
Conditions: Human Papillomavirus Vaccination; Emotions
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Parent/guardian of a 9-12 year old receiving primary care at a Penn State Health clinic
- Their child has not previously received or initiated the HPV vaccine
- Is able to read and understand spoken English or Spanish
- Has a valid email address and access to a mobile phone, table, desktop or laptop computer to engage in the intervention
Exclusion Criteria
- Parent of guardian is less than 18 years of age
- Unable to read and understand spoken English or Spanish
- Does not have access to a mobile phone, table, desktop or laptop computer
Recruiting US locations
Penn State Health
Hershey, PA 17033
Site contact: Ben Fogel, MD · 717-531-7300 · bfogel@pennstatehealth.psu.edu
Study contacts (from the official record)
- William A Calo, PhD · 717-531-3535 · wcalo@pennstatehealth.psu.edu
Similar studies in Pennsylvania
All vaccine studies in Pennsylvania →- RecruitingHealthy volunteersPhase 1/Phase 2
Phase 1/2 Study of Respiratory Syncytial Virus and Human Metapneumovirus (RSV+HMPV) Vaccine Candidate in Adults 60 Years of Age and Older
Sanofi
- Location
- Philadelphia, PA + 49 other US sites
- Eligibility basics
- Ages 60+
- RecruitingHealthy volunteersPhase 1
Phase 1 Study of CH505 HIV Vaccine Nanoparticles and mRNA Boosters in Healthy Adults
National Institute of Allergy and Infectious Diseases (NIAID)
- Location
- Pittsburgh, PA + 1 other US site
- Eligibility basics
- Ages 18–55
- RecruitingHealthy volunteersPhase 1
Clinical Trial to Evaluate the Safety and Immunogenicity of the V2 Apex-Directed Immunogens DV201P-RNA and DV202B1-RNA in Adult Participants Without HIV
National Institute of Allergy and Infectious Diseases (NIAID)
- Location
- Philadelphia, PA + 6 other US sites
- Eligibility basics
- Ages 18–55
- RecruitingHealthy volunteersPhase 3
A Study to Learn About How a New Pneumococcal Vaccine Works in Infants.
Pfizer
- Location
- Bellevue, PA + 101 other US sites
- Eligibility basics
- Ages 1 mo–7 mo